Tag: secondarybreastcancer

Aromatase inhibitors are a class of drugs that can be used to treat hormone receptor-positive (HR+) subtypes of breast cancer1. Aromatase inhibitors can be used in the treatment of early HR+ breast cancer, but here we will focus on aromatase inhibitors in treating secondary (metastatic, advanced) breast cancer.

Living with secondary (metastatic) cancer is challenging. You will deal with a variety of emotions, such as sadness, anxiety, anger, or hopelessness.

When diagnosed with secondary breast cancer, all of the medical terminologies can be very overwhelming. This three part series of posts will tell you a little bit more about the main classifications of secondary breast cancer that are used to direct medical treatments.